Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,780,391
-
Share change
-
+1,487
-
Total reported value
-
$7,454,000
-
Price per share
-
$4.17
-
Number of holders
-
12
-
Value change
-
+$18,959
-
Number of buys
-
7
-
Number of sells
-
4
Institutional Holders of VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) as of Q3 2016
As of 30 Sep 2016,
VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,780,391 shares.
The largest 10 holders included
SPHERA FUNDS MANAGEMENT LTD., New Leaf Venture Partners, L.L.C., SABBY MANAGEMENT, LLC, Parallax Volatility Advisers, L.P., NEXTHERA CAPITAL LP, GEODE CAPITAL MANAGEMENT, LLC, D.A. DAVIDSON & CO., HighTower Advisors, LLC, GOLDMAN SACHS GROUP INC, and LADENBURG THALMANN FINANCIAL SERVICES INC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.